Table 1.
Aggregated data of study exposures and outcomes.
| GWAS ID | Trait | Year | Sample size | Population | Consortium\PMID |
|---|---|---|---|---|---|
| Exposures | |||||
| ebi-a-GCST010681 | T1DM | 2020 | 24,840 | European | 32005708 |
| ebi-a-GCST007515 | T2DM | 2018 | 298,957 | European | 29632382 |
| ebi-a-GCST90002232 | Fasting glucose | 2021 | 200,622 | European | 34059833 |
| ebi-a-GCST90002244 | HbAlc | 2021 | 146,806 | European | 34059833 |
| Outcomes | |||||
| finn-b-G6_EPLEPSY | Epilepsy | 2021 | 182,367 | European | FINNGEN |
| finn-b-FE | Focal epilepsy | 2021 | 213,461 | European | FINNGEN |
| finn-b-GE | Generalized epilepsy | 2021 | 214,313 | European | FINNGEN |
T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; HbAlc, glycated hemoglobin.